Sort   by:  
 Page size 
ProteomicsTCR targeting of KRAS G12V/C neoantigens is enhanced by lymphodepleting chemotherapy
Lung cancer remains the leading cause of cancer-related deaths worldwide. Immunotherapy agents have doubled treatment response rates in non-small cell lung cancer (NSCLC). However, these responses are neither universal nor consistently durable, underscoring the need for innovative therapeutic strate...
ORGANISM(S): Homo sapiens (Human) 
2025-10-03 | PXD061178 | Pride
Lymphodepleting chemotherapy Lung cancer Kras g12v Kras g12c Tcr therapy Neoantigens Colon cancer. Adoptive cell therapy Pancreatic cancer 
UnknownReducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries.
Not available
S-EPMC10364528 | biostudies-literature
UnknownElective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries.
Not available
S-EPMC9621702 | biostudies-literature
Sort   by:  
 Page size